Tests Cerebrolysin during early rehabilitation after ischemic stroke
Tests Cerebrolysin in adults with moderate impairment after acute ischemic stroke.
Plain-language title generated from the registry record
Registry title: Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Key facts
- Where
- Ljubljana, SloveniaSee the site
Where in Slovenia
- UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT)Ljubljana, SloveniaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Centre Ljubljana
- Trial code
- NCT07043686
- Record updated
- 9 July 2025
- Original description
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.Read full original descriptionShow less
Effect of Cerebrolysin on Early Rehabilitation After Ischemic Stroke at the Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), University Medical Centre Ljubljana
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
Inclusion: Being able to perform ARAT test Signed informed consent; Both sexes, age not specified; Acute ischemic stroke confirmed by imaging; NIHSS score 6-12; No prior stroke or disability (mRS 0 before stroke); -.
Exclusion: Previous stroke or disability (mRS > 0); Not being able to perform ARAT test; The patient unable to understand instructions.